StockTipsArenaBeta

BUY Park Medi World Limited — Emkay Global

BUYPark Medi World Limited

byEmkay GlobalHorizon: 1 year18 Jun 2026via Institutional / Brokerage Research

Entry₹255.25Inferred
Target₹350
Total upside +37.12%
Stop lossNot given
CMP₹286.810h ago
Active+12.36%+22.04%upside left 9 mo left
Follow Emkay Global for new calls(65% target hit, 397 closed calls)Get alertsWatch PARKHOSPS for new buy/sell callsGet alertsSee 2 other Long-term calls on PARKHOSPSSee 40 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 2:19 am IST
18 supporting4 neutral0 opposing
Supports the BUY call (18)

Buy healthcare stock for over 41% upside potential, says Ventura; target price | 'Positioned for next growth inflection'

NewsLivemint·2 Sept · 5d ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·1 Sept · 6d ago

Park Medi World Limited's Board of Directors approved the incorporation of a wholly-owned subsidiary, Park Medicity Prayagraj Limited, to develop and operate a 550-bed multi-super-speciality hospital

BSE · Others·31 Aug · 1w ago

(opens in new tab)

Park Medi World Limited's Board of Directors approved the incorporation of a wholly-owned subsidiary, Park Medicity Prayagraj Limited, to develop and operate a 550-bed multi-super-speciality hospital

NSE · Outcome of Board Meeting·31 Aug · 1w ago

(opens in new tab)

Park Medi World targets 5,740-bed network by FY28 under expansion roadmap

NewsLivemint·28 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (4)

Park Medi World Ltd has incorporated a new wholly owned subsidiary, Park Medi World FZE, in the UAE. This move is expected to facilitate business expansion and growth opportunities in the region.

BSE · Company Update·31 Aug · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.